XML 26 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows ( Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash flows from operating activities:    
Net income $ 33,572 $ 34,341
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 10,935 9,808
Amortization of deferred revenue (601) (579)
Amortization of deferred financing costs and debt discount 830 730
Accretion of asset retirement obligations 146 131
Deferred income taxes 119 0
(Income) loss from equity method investments (1,421) 435
Dividends from equity method investments 779 0
Loss (gain) on asset disposals 7 (44)
Unit-based compensation expense 364 233
Changes in assets and liabilities:    
Accounts receivable 932 17,832
Inventories and other current assets 2,041 1,580
Accounts payable and other current liabilities 1,479 (2,113)
Accounts receivable/payable to related parties (1,352) (5,331)
Non-current assets and liabilities, net (419) 566
Net cash provided by operating activities 47,411 57,589
Cash flows from investing activities:    
Purchases of property, plant and equipment (5,867) (2,975)
Proceeds from sales of property, plant and equipment 0 175
Equity method investment contributions (2,937) (33,119)
Net cash used in investing activities (8,804) (35,919)
Cash flows from financing activities:    
Proceeds from issuance of additional units to maintain 2% General Partner interest 21 14
Distributions to general partner (8,231) (4,087)
Distributions to common unitholders - public (12,816) (11,591)
Distributions to common unitholders - Delek (20,772) (6,255)
Distributions to subordinated unitholders - Delek 0 (11,503)
Proceeds from revolving credit facility 139,400 157,850
Payments of revolving credit facility (377,500) (146,900)
Proceeds from issuance of senior notes 248,112 0
Deferred financing costs paid 5,816 0
Reimbursement of capital expenditures by Delek 3,835 802
Net cash used in financing activities (33,767) (21,670)
Net increase in cash and cash equivalents 4,840 0
Cash and cash equivalents at the beginning of the period 59 0
Cash and cash equivalents at the end of the period 4,899 0
Cash paid during the period for:    
Interest 6,940 5,855
Income taxes 29 0
Non-cash investing activities:    
Decrease in accrued capital expenditures (957) (892)
Non-cash financing activities:    
Sponsor contribution of fixed assets $ 67 $ 609